Introduction
As chlorpromazine is the most widely used broad-spectrum antipsychotic 'tranquillizer,' obtaining a thorough knowle.dge of its in vivo metabolism is imperative and may also aid in the elucidation of the mechanism of action of this interesting drug. The two distinctly different sets of transformations involving completely unrelated parts of the CPZ moleoule -oxidation of the aromatic ring system and changes in the aliphatic sidechain -will fit into a rational sequence of metabolic events, which accounts for all of the dozens of urinary metabolites which have been detected or proposed.
Ring Oxidations
The in uitro univalent oxidation of CPZ to a coloured, free radical intermediate by metal cations (Fe-]-", Ce-l-'), concentrated acids or electrolysis has been demonstrated by a variety of electron paramagnetic resonance studies (6) . A complete kinetic study of the CPZ free radical in the peroxidase-H'D, reac-ti~>n has recently been completed by PIette and Yamazaki of Varian Associates (7) . The rate of oxidation of CPZ hy this enzyme is very fast, being comparable to substrates such as ascorbic acid, hydroquinone, etc.
Their results suggest strongly that 'tranquillizers' such 'as CPZ are catalytically oxidized to free radical intermediates .by oxidative enzymes. A significant discovery of this study was the extreme stability of the CPZ radicalalmost seven million times more stable t~an the ascorbate radical at pH 4.8. PIette has postulated that "it is the ex-Amended version of paper presented at the Canadian Psychiatric ,As~ociation Annual Meeting, Vancouver, 1964 trerne stability of such intermediates in the oxidation of the phenothiazine 'tranquillizers' which is responsible for their psychotropic activity."
Kinetic evidence was also obtained for further enzymatic oxidation of the CPZ radical to a thionium ion. Professor Craig of the University of California has shown such phenazothionium ions to be capable of rearrangements and nucleophilic substitutions to form sulfoxides and phenols (2a). These data, therefore, constitute good grounds for the metabolic formation and interconversion of the CPZ phenols and sulfoxides illustrated in Figure 1 . Repetitive oxidative cycles could similarly produce diphenols, phenol-sulfoxides, or even diphenolsulfoxides.
Side-Chain Changes
All of the presently known or postulated aliphatic chain metabolites, as well as a few reasonable additions are shown in Figure 2 . Chlorpromazine N-oxide (C~-NO) which has recently been established as a major metabolite of CPZ (3) 'has been shown by Craig et al (2b) to be capable of transformation into desmethyl CPZ (nor-CPZ under physiological conditions. We have, therefore indicated that its formation is an obligat ory step in the demethylation of CPZ. The 'aliphatic aldehyde which is the normal product of subsequent oxidative deamination steps would be very shortlived i~vivo.ar,td would be expected to be rapidly oxidized to the corresponding N-carboxyethylphenothiazine (CE-2-C1-PTZ). We have now detected two metab:olites ha~ing chemical properties consistent WIth those expected for these acids.
Such aliphatic acids are well known to undergo~-oxidation with the loss of the terminal pair of carbons. This sequence The principal kind of metabolic change which is anticipated in the aromatic ring system is a hydroxylation, at either or both positions para to the nitrogen atom, giving rise to two different monophenols and a diphenol -each of which can also exist as a glueosiduronide or an ethereal sulfate (1) .
Since all of these phenothiazine moieties can also exist in the sulfoxide oxidation state, the number of possible metabolites is doubled to give a total of l68 theoretical metabolites. Fortunately, it appears that not all of the theoretical possibilities are produced. However, it is very likely that there are considerably more than the 27 metabolites which have been postulated in the literature thus far.
[ , III
.s: ALthough CPZ has been studied over a decade, only a very small fraction of its metabolites has been definitely identified. Adequate methods for the extraction of the extremely soluble, amphoteric metabolites have only appeared in the last year (5) . Table I lists the various types of CPZ metabolites in the approximate order of polarities and hence the relative solubilities. The non-polar group of metabolites, constituting about 20% of the total quantity, has been separated nicely, using gas chromatography by Johnson and by Craig.
The polar fractions, constituting the remaining 80% of the drug, as well as the structurally most interesting metabolites, have been the area of our principal effort. We have partially resolved this complex mixture by column chromatography on alumina, silica gel, or
Since it now seems that the metabolic changes of greatest importance to us are those which occur via the free radical intermediate, it would be quite sufficient to be able to distinguish between types of changes in the aromatic portion without regard to differences in the side-chain. The combination of techniques which we have now developed permit such differentiation. x-GIO-CPZ x-HO-y-GIO-CPZ x,y-(GIOh-CPZ HOS020-CPZ florisil, or by gel filtration on Sephadex, However, only thin-layer chromatography (TLC) has accomplished the desired degree of separation.
Using TLC we have resolved tetrahydrofuran (THF) extracts into a large number of metabolites and have recently isolated the first pure sample of any of the highly polar metabolites. Techniques are still being developed for identifying the individual metabolites, but even now it is possible to deduce much about the structures of the components by considering their chemical reactivities and their mobilities in different solvent systems.
Metabolite patterns have consistently been obtained which show minor amounts of components having properties expected of the phenols and major amounts of components having the expected properties of glucosiduronides and of ethereal sulfates. However, in order to properly interpret these metabolite patterns, it is necessary to unequivocally establish the chemical nature of each spot on the chromatogram.
Classical physical techniques are not greatly helpful here because they cannot adequately differentiate between the various types of side-chains. However, one newer technique shows great promise in several respeots. Nuclear magnetic resonance can 'see' individual hydrogen atoms in a molecule and tell how many of each kind are present. Our group at Varian has recently completed cataloguing the chemical shifts due to each individual hydrogen of the pheno-rhiazine nucleus. This information will permit the assignment of the correct structures to any new metabolites which are isolated.
Summary
The present state of our knowledge concerning the metabolism of CPZ in humans is 'as follows:
Non-polar metabolites -All eight of the postulated metabolites have been reported, with nor-CPZ-SO and bis-nor-CPZ-SO being present in the largest amounts and CPZ and CPZ-SO in lesser amounts.
Moderately polar metabolites -Only CPZ-NO is present in substantial amounts. We have detected two acidic, but non-basic, metabolites by TLC and tentatively identified them as N-~-car boxyethyl derivatives. The concentration of free phenols seems to be very low in fresh urine.
Highly polar metabolites -We have seen at least 15 glucosiduronides and/or sulfates by TLC.
The isolation of representative reference compounds from the higWy polar fraction and the determination of their chemical structures will permit the development of analytical techniques for their routine estimation. This information may disclose differences in the metabolic patterns of different patients and may permit the correlating of drug responsiveness with specific metabolic processes.
Obviously, the finding of any anomalous metabolism could have many consequences: it might provide a means of understanding why some patients are drug-responders while others are drugrefractory. Also, vitamins, coenzymes, or other substances which are known to have a role in that particular type of metabolic reaction could be used in an attempt to modify the action of the currently used phenothiazines. Finally, if a certain metabolic pathway is found to lead to either especially high or especially low therapeutic efficacy, medicinal chemists could 'tailor-make' a molecule which either facilitates or blocks that particular metabolic sequence in order to improve the clinical usefulness of the phenothiazine 'tranquillizers'.
Resume
Le metabolisme complexe de la chlorpromazine -loin d'etre entierernent connu-est resume dans ce qui suit:
Metabolites non polaires: les 8 metabolites postules one ete trouves, les produits sulfoxydes dernethyles etant presents en quantites plus importances que la chlorpromazine et son sulfoxyde.
Metabolites de polarite intermediaire:
Seule la epz-NO a ete trouvee en quantite substantielle. Nous avons trouve 2 metabolites acidiques, mais non basiques par chromatographie en couches minces et les avons identifies provisoirement comme derives N-~-carboxyethyliques. Dans les urines fraiches, la concentration de phenols libres parait minime.
Metabolites de polarite prononcee.
Au moins 15 glucosiduronides ou sulfates ontete separes par chromatographie en couches minces.
L'isolation des produits de reference representatifs apartir de la fraction polaire suivie de l'analyse de leurs structures chimiques permettra de developper des methodes de dosage courantes. L'application de ces methodes va servir dans la demonstration des voies metaboliques individuelles, et pourrait permetrre la distinction entre les malades refractaires au regime pharmacotherapeuthique et ceux qui en beneficent, par leurs precedes metaboliques specifiques, Evidemment, toute anomalie metabolique decelee pourrait servir comme point de depart en plusieurs directions:
Les differences metaboliques pourraient nous faire comprendre le succes ou l'echec du regime pharmacotherapeutique. On pourrait se servir des vitamines, des coenzymes et d'autres substances jouant un role dans les reactions meraboliques pour modifier l'action des drogues phenothiaziniques. Finalement, si une voie metabolique paraissait indiquer une efficacite soit excellente, soit minime, les chimistes pharmaceutiques pourraient produire des drogues "sur mesure" soic pour faciliter, soit pour bloquer cette voie metabolique particuliere, pour etendre l'utilite clinique des phenothiazines psychoactives.
